It’s A First (And Second) For IPF: Two Drugs Approved By FDA

FDA approved the first two drugs for the fatal lung disease idiopathic pulmonary fibrosis: Roche’s Esbriet and Boehringer Ingelheim’s Ofev. The simultaneous approvals set the stage for a commercial showdown.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from United States

More from North America